41 related articles for article (PubMed ID: 9935210)
1. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.
Bernal L; Pinzi L; Rastelli G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834548
[TBL] [Abstract][Full Text] [Related]
2. The Role of Nuclear Receptors in Prostate Cancer.
Shiota M; Fujimoto N; Kashiwagi E; Eto M
Cells; 2019 Jun; 8(6):. PubMed ID: 31212954
[TBL] [Abstract][Full Text] [Related]
3. SP1 and RARĪ± regulate AGAP2 expression in cancer.
Doush Y; Surani AA; Navarro-Corcuera A; McArdle S; Billett EE; Montiel-Duarte C
Sci Rep; 2019 Jan; 9(1):390. PubMed ID: 30674964
[TBL] [Abstract][Full Text] [Related]
4. The miR-96 and RARĪ³ signaling axis governs androgen signaling and prostate cancer progression.
Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
[TBL] [Abstract][Full Text] [Related]
5. Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.
Dawson MI; Xia Z; Jiang T; Ye M; Fontana JA; Farhana L; Patel B; Xue LP; Bhuiyan M; Pellicciari R; Macchiarulo A; Nuti R; Zhang XK; Han YH; Tautz L; Hobbs PD; Jong L; Waleh N; Chao WR; Feng GS; Pang Y; Su Y
J Med Chem; 2008 Sep; 51(18):5650-62. PubMed ID: 18759424
[TBL] [Abstract][Full Text] [Related]
6. An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium.
Keedwell RG; Zhao Y; Hammond LA; Wen K; Qin S; Atangan LI; Shurland DL; Wallace DM; Bird R; Reitmair A; Chandraratna RA; Brown G
Br J Cancer; 2004 Aug; 91(3):580-8. PubMed ID: 15266311
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
[TBL] [Abstract][Full Text] [Related]
8. In silico discovery of novel retinoic acid receptor agonist structures.
Schapira M; Raaka BM; Samuels HH; Abagyan R
BMC Struct Biol; 2001; 1():1. PubMed ID: 11405897
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade.
Gyftopoulos K; Perimenis P; Sotiropoulou-Bonikou G; Sakellaropoulos G; Varakis I; Barbalias GA
Int Urol Nephrol; 2000; 32(2):263-9. PubMed ID: 11229646
[TBL] [Abstract][Full Text] [Related]
10. [Retinoid signalling pathways].
Fukasawa H; Shudo K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
[TBL] [Abstract][Full Text] [Related]
11. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
12. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type.
Lu XP; Fanjul A; Picard N; Shroot B; Pfahl M
Int J Cancer; 1999 Jan; 80(2):272-8. PubMed ID: 9935210
[TBL] [Abstract][Full Text] [Related]
13. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
14. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
15. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
